ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66,148 | +12.1% | 3,061 | +0.7% | 0.00% | – |
| Q3 2022 | $59,000 | +20.4% | 3,040 | +26.0% | 0.00% | – |
| Q2 2022 | $49,000 | -58.1% | 2,412 | -38.8% | 0.00% | – |
| Q1 2022 | $117,000 | -49.4% | 3,938 | -60.4% | 0.00% | – |
| Q4 2021 | $231,000 | +110.0% | 9,939 | +180.8% | 0.00% | – |
| Q3 2021 | $110,000 | +900.0% | 3,540 | +1064.5% | 0.00% | – |
| Q2 2021 | $11,000 | -98.0% | 304 | -98.0% | 0.00% | – |
| Q1 2021 | $548,000 | -64.8% | 15,542 | -62.5% | 0.00% | – |
| Q4 2020 | $1,555,000 | +50.1% | 41,461 | +33.6% | 0.00% | – |
| Q3 2020 | $1,036,000 | +20.9% | 31,033 | -4.0% | 0.00% | – |
| Q2 2020 | $857,000 | +507.8% | 32,342 | +276.6% | 0.00% | – |
| Q1 2020 | $141,000 | -58.7% | 8,587 | -36.0% | 0.00% | – |
| Q4 2019 | $341,000 | -10.0% | 13,423 | -29.3% | 0.00% | – |
| Q3 2019 | $379,000 | -35.2% | 18,988 | +4.6% | 0.00% | – |
| Q2 2019 | $585,000 | +40.0% | 18,160 | +40.0% | 0.00% | – |
| Q1 2019 | $418,000 | +34.4% | 12,968 | +2.5% | 0.00% | – |
| Q4 2018 | $311,000 | +101.9% | 12,651 | +170.6% | 0.00% | – |
| Q3 2018 | $154,000 | +285.0% | 4,676 | +315.3% | 0.00% | – |
| Q2 2018 | $40,000 | -80.0% | 1,126 | -81.6% | 0.00% | – |
| Q1 2018 | $200,000 | +23.5% | 6,123 | -3.6% | 0.00% | – |
| Q4 2017 | $162,000 | +362.9% | 6,350 | +282.1% | 0.00% | – |
| Q3 2017 | $35,000 | – | 1,662 | +20675.0% | 0.00% | – |
| Q1 2017 | $0 | – | 8 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |